DaVita Inc – Quartalsfinanzdaten (NYSE:DVA) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit 547.63 M180.01 M324.24 M841.53 M540.73 M 1.89 B Mittelzufluss aus Investitionstätigkeit -247.97 M-162.14 M-67.17 M-262.52 M-163.13 M -654.95 M Zahlungsströme aus der Finanzierungstätigkeit -565.1 M-382.54 M4.45 M-582.16 M-414.52 M -1.37 B Freier Cashflow 376.97 M36.75 M203.15 M675.44 M395.3 M 1.31 B

Nachrichten

DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know

DaVita - Further Upside Is Trickier (Rating Downgrade) (NYSE:DVA)

DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Wall Street Raises Outlook For Three AI Names And This Medical Stock

DaVita: Fortschritte in der Nierenversorgung treiben Aktie auf 52-Wochen-Hoch

Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare

4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts

Alebund vergibt Lizenz für Nierenmedikament AP306 an R1 Therapeutics

Alebund licenses kidney disease drug AP306 to R1 Therapeutics

Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy

4 Stocks Trading Near 52-Week Highs With Room to Rise Further